Oxygenta Pharmaceutical Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 37.02 | 49.79 | 33.93 |
| Operating Expense | 36.45 | 49.50 | 38.01 |
| Net Profit | -2.10 | -1.70 | -4.84 |
| Net Profit Margin | -5.67% | -3.41% | -14.26% |
| Earning Per Share | -0.57 | -0.45 | -1.32 |
| EBIDTA | 0.98 | -0.13 | -2.59 |
| Effective Tax Rate | 0% | 0% | -0% |
Particulars
Jun 2026
Revenue37.02
Operating Expense36.45
Net Profit-2.10
Net Profit Margin-5.67
Earning Per Share-0.57
EBIDTA0.98
Effective Tax Rate0
